Allergan Raises Profit Forecast as Valeant Pursues Bid - Bloomberg -BoardProspects

Allergan Raises Profit Forecast as Valeant Pursues Bid

Bloomberg Oct 9 2014 BoardNews

Profit in the third quarter will be $1.76 to $1.78 per share, above the company’s previous forecast of $1.44 to $1.47, the company said in a statement today. Earnings this year, next year and in 2016 will be higher than analysts are estimating, the Irvine, California-based company said...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- Independent Chairmen Are Smart Investments: Nell Minow also published in Bloomberg
- The Other Duty of Corporate Governance also categorized in BoardNews
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Aeroflot Gains 1st Day in 6 as Navalny Joins Board: Moscow Mover also published in Bloomberg
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
- Management
- hostile takeover